Shanghai Fosun Pharmaceutical purchase 50 percent stake in Guangzhou Nanyang Tumour Hospital

After the cooperation with Shanghai Fosun Pharmaceutical (Group) co., Guangzhou Nanyang Tumour Hospital has become a major force among high-end international tumour hospitals


In recent years, Fosun Pharma has actively developed medical services and has successively purchased many well-known hospitals at home and abroad. Shanghai Fosun Pharmaceutical purchase 50 percent stake in Guangzhou Nanyang Tumour Hospital.It is also devoted to building an international medical aircraft carrier.

The share acquisition of Guangzhou Nanyang Tumour Hospital is an especially important strategic move, by which Fosun Pharma expects that the high-level tumour medical services and extensive international influence of Guangzhou Nanyang Tumour Hospital could be helpful for its entrance into the field of international tumour medical treatment from a higher starting point.

The series of acquisitions reflect the etraordinary strategic vision of Shanghai Fosun Pharmaceutical (Group) and its focus on international medical treatment. Guangzhou Nanyang Tumour hospital is an international authoritative tumour specialized hospital which is well-known in the world and has gained a reputation in both the Asia-Pacific and western countries.

The hospital was founded by Sun Yan, who was the founder of China's medical oncology and a member of the Chinese Academy of Engineering. It is also worth mentioning that the hospital is known as an innovative place for post-doctorate research in Guangdong Province and Guangzhou City.

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

Union Budget

Has Union budget 2017 addressed all requirements of healthcare industry?

Send this article by email